Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate (vol 16, pg 888, 2010)

被引：1
|
作者：
Okeley, N. M.
Miyamoto, J. B.
Zhang, X.
Sanderson, R. J.
Benjamin, D. R.
Sievers, E. L.
机构：
来源：
CLINICAL CANCER RESEARCH | 2011年 / 17卷 / 16期
关键词：
D O I：
10.1158/1078-0432.CCR-11-1753
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5524 / 5524
页数：1
相关论文
共 50 条
  • [31] SGN-CD30C, a new CD30-directed camptothecin antibody-drug conjugate (ADC), shows strong anti-tumor activity and superior tolerability in preclinical studies
    Ryan, Maureen
    Lyski, Ryan
    Bou, Lauren
    Meyer, David
    Jin, Steven
    Simmons, Jessica
    Benjamin, Dennis
    Senter, Peter
    Jeffrey, Scott
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75
    Ryan, M. C.
    Kostner, H.
    Gordon, K. A.
    Duniho, S.
    Sutherland, M. K.
    Yu, C.
    Kim, K. M.
    Nesterova, A.
    Anderson, M.
    McEarchern, J. A.
    Law, C-L
    Smith, L. M.
    BRITISH JOURNAL OF CANCER, 2010, 103 (05) : 676 - 684
  • [33] A Potent Anti-CD70 Antibody-Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
    Jeffrey, Scott C.
    Burke, Patrick J.
    Lyon, Robert P.
    Meyer, David W.
    Sussman, Django
    Anderson, Martha
    Hunter, Joshua H.
    Leiske, Chris I.
    Miyamoto, Jamie B.
    Nicholas, Nicole D.
    Okeley, Nicole M.
    Sanderson, Russell J.
    Stone, Ivan J.
    Zeng, Weiping
    Gregson, Stephen J.
    Masterson, Luke
    Tiberghien, Arnaud C.
    Howard, Philip W.
    Thurston, David E.
    Law, Che-Leung
    Senter, Peter D.
    BIOCONJUGATE CHEMISTRY, 2013, 24 (07) : 1256 - 1263
  • [34] SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models
    Mazahreh, Rebecca
    Mason, Marsha L.
    Gosink, John J.
    Olson, Devra J.
    Thurman, Robert
    Hale, Christopher
    Westendorf, Lori
    Pires, Thomas A.
    Leiske, Christopher I.
    Carlson, Markus
    Nguyen, Liem T.
    Cochran, Julia H.
    Okeley, Nicole M.
    Yumul, Roma
    Jin, Steven
    Stone, Ivan J.
    Sahetya, Disha
    Nesterova, Albina
    Allred, Sean
    Hensley, Kelly M.
    Hu, Rachael
    Lawrence, Robert
    Lewis, Timothy S.
    Sandall, Sharsti
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 421 - 434
  • [35] Exploratory study of brentuximab vedotin (SGN-35), a novel monoclonal antibody-drug-conjugate against CD30, in mycosis fungoides (MF) and Sezary syndrome (SS) demonstrates clinical responses regardless of CD30 expression levels
    Bashey, S.
    Krathen, M.
    Sutherland, K.
    Sundram, U.
    Lingala, B.
    Horwitz, S.
    Hoppe, R.
    Pulitzer, M.
    Advani, R.
    Kim, Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S95 - S95
  • [36] A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells
    Weber, Tobias
    Mavratzas, Athanasios
    Kiesgen, Stefan
    Haase, Stephanie
    Boetticher, Benedikt
    Exner, Evelyn
    Mier, Walter
    Grosse-Hovest, Ludger
    Jaeger, Dirk
    Arndt, Michaela A. E.
    Krauss, Juergen
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [37] Complete remissions with weekly dosing of SGN-35, a novel antibody-drug conjugate (ADC) targeting CD30, in a phase I dose-escalation study in patients with relapsed or refractory Hodgkin lymphoma (HL) or systemic anaplastic large cell lymphoma (sALCL)
    Bartlett, N.
    Forero-Torres, A.
    Rosenblatt, J.
    Fanale, M.
    Horning, S. J.
    Thompson, S.
    Sievers, E. L.
    Kennedy, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] CD70 expression in multiple types of carcinomas: new targets for auristatin-based anti-CD70 antibody-drug conjugate, SGN-75
    Smith, Leia
    Kostner, Heather
    Duniho, Steven
    Nesterova, Albina
    Sutherland, May
    Yu, Changpu
    Kim, Kristine
    Gordon, Kristine
    McEarchern, Julie
    Law, Che-Leung
    Ryan, Maureen
    CANCER RESEARCH, 2009, 69
  • [39] Anti CD-30 Antibody-Drug Conjugate Brentuximab Vedotin (ADCETRIS®) May Be a Promising Treatment Option for Systemic Mastocytosis (SM).
    Mehta, Amitkumar
    Reddy, Vishnu V. B.
    Borate, Uma
    BLOOD, 2012, 120 (21)
  • [40] Potent antitumor activity of the anti-CD19 auristatin antibody-drug conjugate hBU12-vcMMAE in rituximab sensitive and resistant lymphomas
    Gerber, H. P.
    Stone, I.
    Kung-Sutherland, M.
    Miyamoto, J.
    Okeley, N.
    Alley, S. C.
    Meyer, D. L.
    Sussman, D.
    Senter, P.
    Grewal, I. S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 161 - 161
12345